Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP588079.RA_3sompvAkKl50wTkZ8O5uyyb5TqfMcNiQh6hKOCEbfE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP588079.RA_3sompvAkKl50wTkZ8O5uyyb5TqfMcNiQh6hKOCEbfE130_assertion type Assertion NP588079.RA_3sompvAkKl50wTkZ8O5uyyb5TqfMcNiQh6hKOCEbfE130_head.
- NP588079.RA_3sompvAkKl50wTkZ8O5uyyb5TqfMcNiQh6hKOCEbfE130_assertion description "[In conclusion, we believe that the utilization of recombinant desmoglein 1 and desmoglein 3 proteins by ELISA should be used with caution to monitor disease severity and response to therapy, although it remains a high specific test for the initial diagnosis of pemphigus and the identification of a change in the clinical phenotype of this condition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP588079.RA_3sompvAkKl50wTkZ8O5uyyb5TqfMcNiQh6hKOCEbfE130_provenance.
- NP588079.RA_3sompvAkKl50wTkZ8O5uyyb5TqfMcNiQh6hKOCEbfE130_assertion evidence source_evidence_literature NP588079.RA_3sompvAkKl50wTkZ8O5uyyb5TqfMcNiQh6hKOCEbfE130_provenance.
- NP588079.RA_3sompvAkKl50wTkZ8O5uyyb5TqfMcNiQh6hKOCEbfE130_assertion SIO_000772 20049340 NP588079.RA_3sompvAkKl50wTkZ8O5uyyb5TqfMcNiQh6hKOCEbfE130_provenance.
- NP588079.RA_3sompvAkKl50wTkZ8O5uyyb5TqfMcNiQh6hKOCEbfE130_assertion wasDerivedFrom befree-20140225 NP588079.RA_3sompvAkKl50wTkZ8O5uyyb5TqfMcNiQh6hKOCEbfE130_provenance.
- NP588079.RA_3sompvAkKl50wTkZ8O5uyyb5TqfMcNiQh6hKOCEbfE130_assertion wasGeneratedBy ECO_0000203 NP588079.RA_3sompvAkKl50wTkZ8O5uyyb5TqfMcNiQh6hKOCEbfE130_provenance.